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E2F and DP family members are established regula-
tors of the cell cycle. In this study, we examined their 
activity/expression during keratinocyte growth ar-
rest. Treating human epidermal keratinocytes with 
the growth inhibitors TPA or IFN-')' or allowing the 
cells to reach confluence resulted in 90% inhibition of 
DNA synthesis, whereas a keratinocyte-derived squa-
mous carcinoma cell line (SCC25) was resistant to 
growth inhibitors. Gel shift analysis of keratinocytes 
using an E2F response element indicated that growth 
arrest was associated with a decrease in all E2F 
binding complexes. This indicates that growth inhi-
bition is not due to negative regulation by pocket 
proteins. Conversely, gel shift analysis of growth 
inhibitor-resistant SCC25 cells showed no decrease in 
E2F binding. If deregulated E2F expression/activity is 
involved in tumor development, then the deliberate 
deregulation ofE2F activity may make keratinocytes 
resistant to growth inhibitors in much the same way 
as the SCC cells. The HPV16 E 7 protein is known to 
activate E2F. Retroviral infection of keratinocytes 
with E7-expressing constructs resulted in growth in-
T he initial phase of the differen tiatio n pa thway is marked by the irreversible withdrawa l of a prolifer-ative cell popul atio n !Tom the cell cycle. In primary cultures of human e pidermal ke ratinocytes, the tran-sition from proliferation to growth arrest is charac-
terized by the downregulation of expressio n of proliferation-
associated genes such as E2 F1, cdkl , and p5 3 (Saunders and ] e tten, 
1994). After growth arrest, keratuiocytes are commi tted to undergo 
diffe ren tiation and start to express genes required fot· differentia-
tion-specifi c functions, such as transglutaminase type I (S aunders el 
n/, 1993a), corni fin (Marv in 1'1 nl, 1992; Fujimoto et nl, 1993), 
prepmre laxin Qetten et nl, 1992), and CL- 20 (Marvin et a/, 1995). 
T hu s, the pmccss of d ifferenti atio n is chat·acterized by an initial 
repression of pro li fc r<ttion-associatcd ge nes follow ed by the induc-
tion of difte rentiation-specifi c genes. C haracterization of tbese 
even ts is cri tical to underst<tnding the m echanism s involved in 
tumor development because the transition fi:om prolifera tion to 
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hibitor resistance, whereas infection with E6 con-
structs did not. E2F is a heterodimeric complex con-
sisting ofE2F family members (1-5) and DP proteins 
(1-3). Examination of the expression levels for E2F 
genes and other genes associated with the cell cycle 
indicated that E2F1 was profoundly decreased in 
growth-arrested keratinocytes (90%), whereas E2F3, 
E2F5, and DP1 were not. E2F2 and E2F4 were in-
creased in IFN-')'-treated keratinocytes but not in 
TPA-treated or confluent keratinocytes. In contrast, 
SCC25 cells did. not undergo growth arrest and did 
not downregulate E2F1 mRNA expression in response 
to growth inhibitors. Our results indicate that E2F 
DNA binding and in particular E2F1 mRNA expres-
sion are associated with keratinocyte proliferation. 
Our results with the SCC25 cells and the E7-infected 
cells are consistent with the proposition that dereg-
ulated E2F expression/activity (in particular E2F1) 
may be involved in the unregulated proliferation of 
skin tumor cells. K ey words: epithelillmldijfer•entia.tioll!cell 
cycle. J I1west Derma.tol 109:187-193, 1997 
growth arrest is a m aj o r o ncogenic target (as exempli fie d by the 
actio n of DNA tumor viruses o r tumor suppressor gen e inactiva-
tion). 
[n previous work , we identifted two prolifera tion m arker genes 
(E2F1 and cdk1) in keratinocytes and other ep.ithelia (Saunders et a/, 
1993b, 1994; Saunders andjctten, 1994). E2F1 is o nly one m ember 
of a multigene famil y that constitutes E2F. E2F refers to a transcrip-
tio n facto r compl ex comprising an E2F fami ly m ember (numbered 
1 through 5) and <t DP fa mi.ly member (nw11bered 1 through 3) 
(Lam and LaThang ue, 1994). T hese proteins bind as heterodimeric 
complexes to an E2 F response clem ent in the promoters of critica l 
growth genes and regulate transcriptio n and ultimately proliferation 
(Nevins, 1992; Helin eta/, 1993; Lees eta/ , 1993). During cell cycle 
traverse, the E2F activity is coordinate ly regu]a ted (i) by changes u1 
transcription of the E2Fl gene (Hsiao et a/ , 1994; J o hnson et n/, 
1994), (i i) by interactions with pocket proteins (e.g., Rb, p1 07, ot· 
p130) , or (iii) by direct phosphory lation (e.g., E2F1; Fagan et a/, 
1994; KJ·ck eta/, 1995) . Prev ious reports ha ve indicated that -the 
vari o us stages of the cell cycle are associated w ith th e activation / 
inactivation of v<trious E2F complexes. For instan ce, G 0 (quies-
cence) is associated w ith E2F4:pl30 OJ' E2F5:p130 inhibitory com-
plexes, whet·eas G ,/ S tran sitio n is associated with E2F1, E2F2, or 
E2F3:Rb interactions or E2F4:p107 interactions (Moberg et a/, 
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1996) . E2F can also be regulated by alterations in E2F gene 
expression. For instance, we have previously demonstrated that 
during growth arrest, E2Fl mRNA is downregulate d (Saunders el 
al, 1993b, 1994; Saunders and ] e tten , 1994). Given the recent 
cloning and c haracterization of other m e mbers of the E2F tran-
scription f.,ctor family, however, it is now unknown whether the 
downregulation of E2Fl we reporte d previously is indica tive of a 
g lobal change in E2F fLmction/activity in differentiating keratino-
cytes. For instance, all the .E2F f.,mi ly members bind as het-
erodimers to an E2F response element and can trmJS-activate E2F 
reporter genes (Lees el a/ , 1993 ; Wu el nl, 1995) . Thus, a detailed 
examination of E2F expression and activity in differentiating epi-
thelia is required to understand the ro le of this important class of 
cell-cycle regulators in epith e lial differentiation. 
In the current study, we demonstrate that irreversible growth 
arrest is associated with a decrease in all E2.F DNA binding 
complexes. Our data indicate that kera tinocyte proliferation is 
associated with E2F activity and that u.pon differentiation, E2F 
activity and E2Fl mRNA expression are decreased. Our data are 
also consistent with the proposal that deregulated E2F expression/ 
activity, and in particular E2F1, may contribute to the unregulated 
proliferation characteristic of tumor cells. 
MATERiALS AND METHODS 
Cell Culture and DNA Synthesis Assays The tongue-derived squa-
mous carc inoma ce ll lin e (SCC25) was purchased fi·om American Type 
Culture Collec tion (Rockville, MD) and cultured in a 1:1 mixture of Ham's 
F1. 2 and Dulbecco's modified Eagle's medium supplemented with 1 0'11,, fe tal 
bovine serum, 0.4 J.Lg hydrocortisone p er ml , ,peniciUin/strcptomycin 
(1 0,000 U per ml) , and 10 J.Lg gentamicin per ml. Human ep idermal 
keratinocytes were trypsinized (0. 25'Y., trypsin/versenc) from neonatal 
fore skins after a 24-h incubation in 2.5% dispase (G!BCO Blli, Gaithers-
bLtrg, MD) at 4°C. First-passage keratinocytes were maintained in 3:1 
medium (Dulbecco ' s modified Eagle's medium:Harn's F12, 3:1 vollvol 
supplemen ted with 1.0,000 U penicillin/streptornycin per ml, 5 J.Lg trans-
fen:in per ml , 5 J.Lg insuli11 per ml, 8.4 ng cho le ra toxin pe r ml , 240 ng 
hydrocortisone per ml, 34 J.Lg adenine per ml , and 1 0 J.Lg gentamicin pe1· ml) 
in the absence of epidermal growth fa ctor for 48 h. T lli s medium was then 
replaced with 3:lmedium supplemented with 2 ng epidermal growth factor 
per ml (Sigma, Sydney, Australi a). Subsequent passages were maintained in 
serum-free keratinocyte mediu!'l (GIBCO Life Technologies, Ga ithersburg, 
MD) supplemented with 1.0 ,000 U pmlicillin/streptomycin per ml and 10 
J.Lg gentamici11 per ml. 
Un.less otherwise stated, keratinocytes were growth arrested by treating 
with 300 U IFN-y per ml or SO ng 1.2-0-tetradecanoyl-phorbol-1 3-acetate 
(TPA) per ml , or by maintaining the cell s as confluent cultures for 48 h. 
DNA synthesis was assayed by determining thymidine incorporation, as 
described (Saunders et a/, 1993 b; Saunders and ]etten, 1994). 
Reverse Transcriptase-Polyrnerase Chain Reaction (PCR) and 
Western Blot Analysis Total RNA was ex tracted from keratinocytes 
with TRlzol (Life TeclUlologies, Sydney, Australia). Preliminary ampLifica-
tion time courses were performed to estab li sh the number of cycles at which 
amplification of product was linear, and aU subsequent amplifications used 
the same condition for each individual oligonucleotide pair. The fo llowing 
oligonucleotides were synthesized and used in standard 50-JLI PCR reac-
tions: 5' E2Fl TGACCATCAGTACCTGGCCGA; 3' E2F1 AGGCGGAG-
GTGGTAGTCGAGG; 5' E2F2 CAAGTTGTGCGATGCCTG; 3' E2F2 
TAGTCGTCCTGGTCCAAG; 5' E2F3 GATCGGATCCATGGCAAAGC-
GAAGGCTGGA; 3' E2F3 CTAGGATCCGGATCGAAGGAGAGTTCA-
C ACGAAGC; 5' E2F4 GCGGAGGCCGGGCCACAG; 3' E2F4 CTG-
CAGTGGCCGGGTGTC; 5' E2FS TCTCTTGGCCTGCTGCCT; 3' E2FS 
ATCCCTCCATTTTCATTG; 5' p1 07 TACGGCTTCTGAAGAGCCA; 
3' p107 ACGAGGTGAGCTATAGGC; 5 ' DPl TGAGCCAACGGAGA-
ACTCAA; 3' DPl GGCAGACCAATCCACTTGATC; 5' actin GAAAT-
CGTGCGTGAC ATTAAG; 3' actin CTAGAAGCATTTGCGGTGGAGA-
TGGAGGGGCC. 
For protein analysis, 40 J.Lg of tota l cellular protein from keratinocytes was 
denatured and run on a 10% sodium dodecyl su lfa te-polyacrylamide gel and 
blotted to J-lybond C (Amersham , Sydney, Austra li a) as described (Saunders 
et a/, 1993b) . E2F1. was then detected with a mouse monoclonal antibody 
(sc-2 51 San ta- Cruz Biotech. Santa C ruz, CA) and chemiluminesccnt 
detection (ECL, Amersham) as per the manufacturer's protocol. 
Pbospborimage Analysis Southern b lo ts of the am pli fication reactions 
were prehybridized and hybridized at 42°C in a buffer containing 2 X 
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Denhardt's, 3 X sodium citrate/ ch.loride buffer, 1% sodium dodecyl sulfate, 
10 J.Lg sheared sa lmon sperm DNA per ml, and 0.04 M phosphate buffer. 
Blots were probed with the respective [y-32 P]ATP-labeled 3' oligonucleo-
tide for 24 h before exp\)sure to a phosphot;mage screen (Molecular 
Dynamics, Slllmyvale , CA). The image was analyzed on an LKB phospho-
rimager. Inequalities in reverse transcription and amplification were nor-
Jn aJized to actin expression. 
Nuclear Extract Preparation and Gel Shift Analysis Nuclear ex-
tracts were prepared as fo llows. Cell s were scraped from 150-mm dishes 
(th1·ee for each treatment) and washed in phosphate-buffered sa line. The ce ll 
pellet was washed in 5 volumes of a hypotonic buffer (1 0 mM HEPES, pl-1 
7.4. 1.5 mM MgCI2 , 10 mM KCl, 0.5 mM dithiothrcitol, 0 .5 mM 
phenylmethylmlfonyl fluoride, 5 J.Lg each of aprotinin and leupeptin per ml) 
and incubated on ice for 30 min. Nonidet P-40 was added to 0.05% (final 
concentration), and the cell s were lysed by Dounce homogeniza tion in a 
tight-fitting Dounce. Nuclei were pelleted at 250 X g for 10 min at 4°C. 
Nuclear pellets were resuspended i11 icc-cold extraction buffer (5 mM 
HEPES, pH 7.4, 26% glycero l, 1.5 mM MgC1 2 , 0.2 mM ethylenediami-
ne tetra-ace tic acid , 0.5 mM dithiothreitol, 0.5 mM phenylmcthylsulfonyl 
Aum·ide, and 5 J.Lg each of aprotinin and leupcptin per ml) and gently 
agitated at 4°C for 1 h. Insoluble nuclear material was pelleted (13 ,000 X g 
for 20 min at 4°C), and the supernatant was stored at - 70°C. 
A double-strand oligonucleotide corresponding to the E2F response 
element in the adenov irus E2 early promoter was synthesized (S'ATTTA-
AGTTTCGCGCCCTTTCTCAAA 3 ' ) and used to examin e E2F binding 
in keratinocytes and SCC25 ceUs. Binding conditions were as follows : 3 J.Lg 
nuclear extl·act, 4 J.Ll of 5 X binding buffer (20% glyce ro l, 5 mM MgCJ2 , 2.5 
mM cthyl enediaminetctra- acetic acid, 2.5 mM dith.iothrcitol, 250 mM 
NaCl, 50 mM Tris-HC l, pl-1 7.6) , 0.3 J.Lg sheared sa lmon sperm DNA, and 
20,000 cpm 32P-labelcd double-stranded oligonucleotide . Where indicated , 
binding reactions were incubated with approximately 200-fold excess 
specific or nonspecifi c DNA for 15 min before the binding assay. The 
DNA/protein complexes were separated on a pre-electrophoresed S'X, 
polyacrylamide gel in 0.2S X TBE buffer fo r 2 h at 12 mAmp. The gel was 
immediately dried and exposed to Kodak X -OMAT-AR Scientific imaging 
fi lm. 
Retroviral Infection R.e troviral constructs expressing the human pap-
illomavirus (HPV) 16 E6 or E7 gene products have been described 
previously, as has the infection protocol (Halbert et nl , 1992). 'Passage- 2 
proliferating keratinocytes (25% conJlnence) were infected with the retro-
vira l constructs and 24 h la ter were se lected with G418 (150 J.Lg per ml). 
Successfully infected cells were then passaged and used as required. H..everse 
transcriptase-PCR ana lysis on DNase !-treated RNA samples confim1ed the 
expression ofE6 or E7 in the appropriate ce ll Lines (data not shown) , and no 
cross-infection was detec ted . 
RESULTS 
E2F Activity Is Downregulated During Keratinocyte 
Growth Arrest Previous studies (Saunders et nl, 1993a, 1993b; 
Saunders and J e tten, 1994) have established that kerati:nocyte 
growth arrest and differentiation can b e initiated by allowing 
kerati:nocytes to become confluent or by t rea ting with the protein 
kinase C activator TPA (50 ng p e r ml) or with lFN - y (300 U per 
ml) . Figure 1A confirms that these stimuli markedly inhibited 
DNA synthesis in cul tures of proliferating keratinocytes. 
E2F is th e downstream effector of many cell-cycle control gen es. 
Consequently, we exam ined the activity of tlus transcription factor 
complex in proliferating keratinocytes and keratinocytes induced to 
growth arrest. Figure 1B shows that proliferating ke ratinocytes 
bad at least five DNA binding complexes (labele d "a-e") that 
bound in a ge l shift assay to th e consensus E2F response e le ment. 
Complexes "a" through "d" were competed off by unlabeled 
probe, whereas complex " e " was a non specific co.mplex that was 
competed off by a 200-fo ld excess of specific or nonspecific probe. 
The effects of va r·ious growth inhibitor·s on these complexes were 
examined. It is noteworthy th at E2F binding was not totally 
abolish ed by growth an·est, but was characterized by (i) a profound 
and generalized decrease in binding ·and (ii) a selective loss of 
complexes "b," "d," and to a lesser extent "a" and "c" (Fig 1B). 
ln addition, different means of inducing growth arrest were asso-
ciated with differential loss of particular E2F binding complexes. 
For instance, growth arrest induced by confluence gave the most 
pronounced growth inhibition (Fig 1A) and gave the greatest 
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decrease in both the binding and loss ofE2F binding complexes. In 
contrast, growth arrest induced by TPA or IFN-')' was associated 
with loss of complex "b" and "d" and, to a lesser extent, "a," but 
with retention of small amounts of complex "c." 
To clarify further the molecular events underlying keratinocyte 
growth arrest and the associated decrease in E2F transcription factor 
binding, we examined the effect of growth arrest on expression of 
the various E2F genes and DP1 (Fig 2). Of the E2F genes studied, 
only E2F1 mRNA was downreguJated in growth-arrested kerati-
nocytes. No consistent association between E2F2, E2F3, or E2F4 
expression and proliferation was found . In fact, E2F2 and E2F4 
were induced by treatment ofkeratinocytes with IFN-')'. Consistent 
with a role in reversibly growth- arrested (quiescent) cetls, E2F5 
was moderately induced in all growth- arrested ceU populations. 
The DP proteins have been found to be constitutively expressed in 
cycling cells. In keratinocytes, DP1 expression was not correlated 
with proliferation status . Similarly, expression of the pocket protein 
p107 showed no association with keratinocyte proliferation (data 
not shown) . Because E2F1 was the only E2F family member whose 
mRNA expression was downregulated upon growth arrest, we 
examined E2Fl protein levels in the presence of growth inhibitors. 
Westem blot analysis ofE2F1 protein levels (Fig 3) in proliferating 
and growth-arrested keratinocytes indicated that only moderate to 
undetectable decreases in E2F1 protein levels occurred during 
growth inhibition. This was in contrast to the rnRNA and E2F 
activities under similar conditions . The lack of a decrease in E2F1 
protein was not antibody specific, as we found similar results in 
inununoprecipitations with a polyclonal (Santa Cruz) or monoclo-
nal (Santa Cruz) antibody generated against different epitopes 
followed by detection with the same antibody used in the irnmu-
noprecipitation or a different antibody (unpublished data) . The lack 
of correlation between E2F1 protein levels and proliferation status 
was reported recently for mammary epithelial cetls (Harvat and 
]etten, 1996). Thus, the amount of immunoreactive E2F1 protein 
does not correlate with DNA synthesis, with changes in E2Fl 
mRNA levels, or with E2F DNA binding activity. Combined, our 
data indicate that activation of various growth-inhibitory signaling 
pathways in keratinocytes induces a series of events that ultimately 
converge to produce a profound decrease in E2F DNA binding 
activity and a marked decrease only in E2F1 mRNA. 
Squamous Carcinoma Cells Do Not Downregulate E2F in 
Response to Growth Inhibitors We have shown previously 
that various keratinocyte-derived squamous carcinoma cell lines are 
...J 
~ 
Sp.Comp. 
,.. <5 tt ~ z g: zs !!: 
Nonsp. Comp. 
.... It ~ z 0 II: 
E2F fN KERATINOCYTES 189 
Figure 1. E2F DNA binding activity 
is decreased in growth-arrested kera-
tinocytes. (A) Estimates of DNA synthesis 
were assayed by thymjdine incorporation 
(see Materials a11d L'vfcrhods). Proliferating 
keratinocytes (PROL) were treated with 
50 ng TPA per ml (48 h) or 300 U TFN-y 
per ml (48 b) or were .left to grow to 
confluence (DIFF). Data are presented as 
mean ± SEM of triplicate determinations 
of two experiments and represent the 
percentage of proljferating keratinocyte 
values. (B) Gel shift analysis ofE2F bind-
ing activity (see Materials a11d Methods) 
was perforn1ed on nuclear extracts fron1 
proliferating keratinocytes (PROL), con-
fluent keratinocytes (DIFF), or keratino-
cytes treated with TPA (50 ng per ml for 
48 h) or lFN-y (300 U per ml for 48 h). 
Protein:DNA binding complexes are la-
beled (a-e). Binding activity was assayed 
.in the absence or presence of 200-fold 
excess unlabeled specific competitor 
(Sp. Comp.) or nonspecific competitor 
(Nonsp. Comp.). This experiment was 
performed on at least three different 
preparations, but only one is shown. 
resistant to the growth-inhibitory properties of IFN-')' (Saunders 
andJetten, 1994; Saunders eta/, 1996). We examined the sensitivity 
of a keratinocyte-derived squamous carcinoma cell line (SCC25) to 
various growth-inhibitory stimuli (Fig 4A). Botl1 TPA and IFN- ')' 
failed to inhibit proliferation, whereas allowing the cells to reach 
confluence resulted in a moderate (35%) reduction in DNA syn-
thesis. Previous studies with IFN-')' in carcinoma cells have indi-
cated that growth inhibitor insensitivity is not due to a lack of 
receptor function (Saunders and ]etten, 1994), and thus we exam-
ined whetl1er the lack of growth inhibition was associated with a 
failure to downregulate E2F activity in these cells. A comparison of 
E2F DNA binding activity between nuclear extracts ofpro.liferating 
and growth inhibitor- treated SCC25 cells demonstrated that there 
was no decrease in E2F binding activity in response to TPA, IFN-')', 
or confluence (Fig 4B). The gel shift analysis also revealed that 
SCC25 cells had significantly more E2F activity than keratinocytes 
(Fig 4B) and that E2F binding involved several binding complexes. 
Conditions that resulted in decreased E2F binding in keratinocytes 
increased the binding of a low-mobility complex in SCC25 cells 
(Fig 4B, **). Like keratinocytes, the SCC25 E2F DNA binding 
complexes were competed off by unlabeled probe, but not by 
nonspecific probe (not shovm), with the exception of a high-
mobility nonspecific binding complex (Fig 4B, *). 
Examination of the mRNA levels for the various E2F family 
members in SCC25 cells indicated that tl1ere was a moderate 
decrease in E2F1 expression (0.3- to 0 .5- fold; Fig 5) compared 
with normal keratinocytes (at least 5-fold; Fig 2). The profile for 
E2F4 mRNA expression between normal keratinocytes and SCC25 
cells in response to growth-inhibitory regimens was similar. In 
contrast to our observations with normal keratiuocytes, expression 
levels of E2F3 and E2F5 were decreased in TPA- and IFN-')'-
treated SCC25 cells. T IJ..is decrease was not associated with aiter-
ations in E2F binding complexes or growth inhibition (Fig 4), 
wiJ..ich suggests that the regulati.on of their mRNA expression is not 
associated with the regulation of proliferation or E2F activity in 
these cells. These data indicate that the growth- inhibitor resistance 
of the SCC25 cells correlates widt the inability of these cells to 
downregulate E2F1 mRNA expression and E2F activity. 
.Deliberate Deregulation of E2F Is Associated With 
Growth-Inhibitor Resistance It is established that E2F trans-
activation and hence proliferation are deregulated in cells infected 
with DNA tumor viruses such as HPV16 (Nevins , 1992) . This 
action has been attributed to the ability of a specific protein (E7) 
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Figure 2. E2Fl mRNA expression is decreased during keratinocyte 
growth arrest in normal human keratiuocytes. Proliferating keratino-
cytcs were either untreated (PROL) or growth arres ted with TPA (50 ng 
per ml) or TFN-y (300 U per ml) for 48 h or were allowed to grow to 
confluence (DfFF) . RNA was isolated and subjected to reverse transcrip-
tase-PCR, as described in Materials a11d !Yfet/wds. Expression levels were 
detennined by probing blots of PCR products generated under linear 
conditions wi th the appropriate 321>-labeled oligonucleotide and were 
quantified by phosphorimage ana lysis. All expression levels were normal-
ized for actin expression. Data are presented as a percentage of proliferating 
keratinocytes (mean :': SEM fo r three e":perimen ts) . 
th at binds the hypophosphorylated form of the pocke t proteins, 
resulting in the "freeing" up of E2F and hence constitutive E2F 
ac tivation and cell proliferation (Nevins, 1992) . HPV16 E6 prote in, 
on the other h and , m ediates its actions through apparently E2F-
independent pathways involving p53. To test the hypothesis that 
deregulated expression ofE2F activity contributes to tumor devel-
opment, we introduced the HPV16 E7 protein or the E6 protein via 
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Figure 3. E2F1 protein expression in normal human keratinocytes 
or SCC cells is not downrcgulated by growth inhibitors. Untreated 
keratinocytes (Prol), cells treated with TPA (50 ng per ml) or IFN-y (300 U 
per ml) for 48 h, or those left to become confluent (Confl) were harvested 
into protein sample buffer, and 20 !Lg was run on a 7.5% sodium dodecyl 
sul fate -polyacrylamide gel. Proteins were tben blotted and probed with an 
anti-human E2Fl mouse monoclona l antibody (1:1000, Santa Cruz). E2F1 
expression levels were visualized by luminescence detection. 
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Figure 4. E2F DNA binding activity is not dowuregnlated in 
squamous carcinoma cells treated with growth inhibitors. (A) 
Estimates of DNA synthesis were detennined by a thymidine incorporation 
assay (see Materials am/ Methods). SCC25 cells were either untreated (PROL) 
or treated with 50 ng TPA per ml (48 h) or 300 U IFN-y per ml (48 h) or 
were left to grow to confluence (CONF). Data are presented as mean :': 
SEM of triplicate determinations of two experiments and represent a 
percentage of untreated cell values. (B) Gel shift analysis of E2F binding 
activity (see Materials and Methods) was performed on nuclear extracts from 
untreated keratinocytes (HEK; Pro!) or SCC25 cells (Prol), confluent 
SCC25 cells (Confl), or SCC25 cells treated with TPA (50 ng per ml for 
48 h) or IFN-y (300 U per m1 for 48 h) . This experiment was perfonned on 
at least two different preparations, but only one is shown. Keratinocyte 
binding complexes cannot be seen because of underexposure. *Nonspecific 
binding complex; **specific low-mobility binding complex. 
retroviral infection of primary cultures of normal human epidermal 
keratinocytes . The E6-infected cells behaved similarly to normal 
kerati.nocytes, although the confluent cells retained ahnost 50% 
DNA synthesis activity (Fig 6) . In contrast to the E6-transduced 
cells and nonnal keratinocytes, the E7-ex pressing cells showed 
considerable resistance to growth-inhibitory stimuli. Our data 
indicate that sensitivity to growth inhibitors correlates most closely 
with E2F1 mRNA expression. Consistent with tlti.s, Fig 6 indicates 
that the E7-transduced keratinocytes were not only nonresponsive 
to growth inhibition, but were also characterized by loss of 
responsiveness of E2F1 mRNA expression to growth-inhibitory 
stimuli. In contrast, the E6 cells that were growth-inhibitor sensi-
tive h ad decreased levels ofE2F1 mRNA. These data suggest that 
signaling pathways regulating E2F1 mR.NA expression and growth 
arrest are associated and that the mechanisms regulating E2F1 
mRNA expression may be causally associated with the control of 
growth arrest. 
DISCUSSION 
We have shown that induction of keratinocyte growth arrest is 
associated with the activation of signaling pathways leading to 
decreases in E2F DNA binding activity and E2F1 mR.NA expres-
sion. In contrast, carcinoma cells are unable to activate these 
pathways in response to growth inhibitors and do not undergo 
growth arrest. With respect to the molecular mechanisms control-
ling irreversible growth arrest in differentiating keratinocytes, our 
study supports a bipartite model involving decreases in both gene 
expression (exemplified by E2F1) and the activity of critical 
cell-cycle genes (e.g., E2F). In tllis model, a growth-inhibitory 
stimulus invokes a cascade of events that in the short term prevents 
cell-cycle progression (decreased E2F activity) and in the longer 
term prevents the production of critical cell-cycle regulatory genes 
such as E2F1. The control of these two processes may involve 
different mechanisms . Although not specifically addressed in our 
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study, our data suggest that regulation of E2F1 gene expression is 
an important event in the pathway regulating kera tinocyte growth 
anest. This is highlighted by the observation that the growth 
inhibitors (TPA, IFN-y, or confluence) operate thl'ough indepen-
dent signaling pathways ye t appear to converge upon similar 
targets , namely E2Fl (Saunders et a/, 1993b; Saunders and ]etten, 
1994) . Furthermore, we show that carcinoma cells that are resistant 
to growth inhibitors are unable to activate the pathways leading to 
E2F1 m.R.NA downregulation. In the current study, this was 
demonstrated in SCC25 cells; however, we and others have 
reported simi lar findings in other SCC cell lines (Saunders and 
] e tten, 1994), lung carcinoma cell lines (Saunders cl al, 1993a) , and 
breast carcinoma cell lines (Harvat andjetten, 1996) with respect to 
lFN-y-induced growth inhibition. The intimate association be-
tween the signaling pathway linking E2Fl mRNA downregulation 
with growth an-est was further demonstrated in HPVl6 E7-
transduced keratinocytes. ln this study, normal keratinocytes that 
responded to growth inhibitors became growth-inhibitor insensi-
tive by introduction of the HPV16 E7 gene . T he E7 gene selectively 
activates E2F by dissociatiJlg E2F from pocket proteins. Combined, 
these data suggest that the downregulation ofE2F1 mRNA expres-
sion is an integral part of the signaling pathways associated with 
E2F1 E2F-2 
E2F3 E2F4 
E2F5 DP1 
Figure 5. E2F1 mRNA expression in squa1nous carcinotna cells is 
not decreased after treatment with growth inhibitors. Prolifera ting 
SCC25 cells were either untreated (PROL) or treated with TPA (50 ng per 
ml) or IFN-')1 (300 U per ml) for 48 h or were allowed to grow to confluence 
(CONF). RNA was isolated and subjected to reverse transcrjptase-PCR, as 
descti bed in Materia ls a}l(/ Methods . Expression levels were determined by 
probing blots of PCR products generated under linear conditions with the 
approprjate 3 2 P-Iabeled oligonucleotide and were quantified by phospho-
rimage ana lysis . Al l expression levels were normalized for actin expression. 
Data are presented as mean ::':: range for two experiments (except E2F2, n = 
1). Data represent a percentage of untreated cell values. 
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Figure 6. Deregulated expression ofE2F1 is associated with dereg-
ulated keratinocyte proliferation. Proliferating keratinocytes were in-
fected with retrovira.l constructs containing the HPV1 6 E6 or E7 reading 
fi·ames (see Materia ls a11d fllletltods) , and expressing cells were selected in 
G418. Proliferating keratinocytes (PROL) were then treated with 50 ng 
TPA per ml (24 h) or 300 U lFN-y per ml (24 h) or were left to grow to 
confluence (CONF). A DNA synthesis assay was used to estimate prolifer-
ation and is presented as the mean ::':: SEM of triplicate determinations of 
two experiments. E2Fl mR.NA expression was determined by reverse 
transcriptase-PCR (normalized for actin mqJrcssion) . Data represent a 
percentage of proliferating keratinocytes. · 
keratinocyte g rowth arrest, as is the inhibition of DNA binding 
activity. 
DNA binding is a prerequisite for E2F-mediated tra~~s-activation 
of genes required for proliferation , and thus the loss ofE2F binding 
in kera tinocytes is consistent with the absence of proliferation. 
Because each of the E2F family members has the ability to bind and 
tra11s-activate via an E2F response element, however (Lees et a/, 
1993; Wu eta/, 1995), it was necessary to examine the expression 
patte rns for other E2F family members to determine (i) whether 
their expression was sin1ilarly regulated during growth arrest and 
(ii) their potential role in both growth arrest and the decrease in 
E2F binding that accompanies growth arrest. Unexpectedly, we 
found that expression ofE2F family members (other than E2F1), as 
well as of the heterodimeric partner DP1, was not correlated with 
proliferation status. These data were unexpected for several rea-
son s. In the first instance, reversibly growth- arrested cells (quies-
cent) contain E2F DNA binding activity that is thought to comprise 
complexes containing E2F4 or E2F5 (Ginsberg et a/, 1994; Saredet 
et al, 1995; Vairo et a/, 1995). In contrast, we did not observe an 
increase in E2F DNA binding complexes during keratinocyte 
differentiation. On the contrary, there was a general decrease in all 
binding complexes. Even the moderately decreased levels of com-
plex "c" (Fig 1B) in proliferating ''ers11s growth-arrested keratino-
cytes could not be attributed to a growth atTest-specific comp.lex. 
as the binding assay was done with saturating probe concentrations 
and only a minor fi·action of the proliferating keratinocytes would 
be growth arrested at any one time. If a growth arrest-specific 
complex w ere present, a complex present in the proliferating cells 
would be expected to in crease in the growth-arrested cells . Such a 
complex was not evident. These fmdings indicate that irreversible 
growth arrest is not mediated by negative regulatory complexes 
containing pocke t proteins, cyclin-dependent kinase inhibitors , or 
quiescence-specific E2Fs such as E2F5. 
D isruption ofE2F activity appears to be the ultimate downstt:eam 
target for many oncogenic events. For instance, DNA tumor virus 
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proteins such as HPV16 E7, SV40 T antigen, and adenovirus ElA 
all bind hypophosphorylated pocket proteins, resulting in deregu-
lated E2F activity (Nevins, 1992; Melillo et al, 1994) . ln addition, 
E2F activity is a downstream target for other oncogenic events such 
cyclu1 D amplification, Rb deletion, or p16 deletion/mutation 
(Strauss eta/, 1995). One of the characteristics of tumor cells is their 
deregulated growth, which is reA.ected in their u1ability to respond 
to growth inhibitors (Reiss eta/, 1993; Saunders and Jetten, 1994; 
Saunders et al, 1994, 1996; Harvat and Jetten, 1.996) . This obser-
vation led us to explore the possibility that the nonresponsiveness of 
a keratinocyte-derived carcinoma cell line may be linked to dereg-
u lated E2F expression and activity. Carcin oma cells proved resistant 
to growth i11hibitors, which was associated with (i) an inability to 
dowmegu.late E2F bi11du1g activity and (ii) a lack of decrease in 
E2Fl mRNA expression. T he decrease in E2F3 and E2FS and the 
increase in E2F4 with respect to TPA and IFN-y treatment were 
not associated with alterations in proliferation or in E2F DNA 
biJ1ding activity . T his indicates that E2F3, E2F4, an d E2FS mRNA 
expression levels are poor markers ofE2F activity and growth and 
suggests that signalu1g pathways controlling keratiJ1o"cyte prolifer-
ation and E2F1 are dissunilar to those regulating E2F3, E2F4, or 
E2FS. If the growth-inhibitor insens itivity of the carcinoma cells 
were due to deregulated E2F activity, we predicted that the 
deliberate deregulation ofE2F activity by HPV16 E7 overexpres-
sion may result in a growth irihibi tor-insensitivc phenotype similar 
to the SCC25 cells. This was indeed the case, as E7- expressing cells 
were insensitive to growth inhibitors and were characterized by an 
u1ability to downregu late E2F1 expression. Previous studies have 
established that the presence ofE7 protein leads to the activation of 
a growth-stimu latory E2F activity. O ur data are consistent with the 
proposition that de regu lated E2F activity, in particu lar E2F1, is 
associated with the tumor phenotype. T his is supported by our 
examination of two models ofhuman tumor types, namely a human 
keratinocyte-derived squamous carcinoma cell Line and cells ex-
pressi11g the transforming prote in fi·om the HPV16 D N A tum or 
virus. Both of these con ditions resulted in cells that were growth-
inhibitor in sensitive and were unabl.e to downregulate E2Fl ex-
pression or activity. 
Progression through th~ ceLl cycle is controlled by a complex 
series of tran scriptional and post-translational processes tha t influ-
ence E2F activity and hence proliferation (Nevins, 1992). Our data 
indicate that keratinocyte growth at:rest is accompanjed by a 
decrease in E2F activity. Although E2F comprises fiv e family 
members, only E2F1 mRNA expression was decreased during 
growth arrest, bu t the decrease in E2Fl expression did not correlate 
with E2F1 protein levels. Superficially, this suggests that E2F1 
activity may not be associated with kcratinocyte proliferation . It has 
been demonstrated, however, that E2Fl and E2F DNA bu1ding 
activity are both inhibited during the G2/M phase of the cell cycle 
by direct phosphorylation (Fagan ct al, 1994; Krek et a/, 1995). 
Thus, m easures of E2Fl protein levels (or those of other fiunily 
members) may not reflect E2F activity, and the persisten t expres-
sion of E2F1 protein after mRNA dowmegulation noted in this 
study may reflect protein stabi li ty rather than activ ity. E2F was 
recently reported to be sta bilized when in a " no nactive" form 
(Hateboer e/ a/, 1996; Hofinann e/ al, 1996). Consisten t with the 
persistence of E2Fl protein expression, we have found that the 
m;Dority ofE2F u1 nuclear extracts _fi·om. growth-arrested keratino-
cytes is present in a uonbu1du1g phosphorylated form Oones and 
Saunders, in preparation). If p hosphoryla tion ofE2P is an unportant 
regulator of DNA binding activ ity, as has been reported in other 
cell lines, then ca rcu1oma cells may also possess defects li1 the 
enzyme(s) catalyzing E2F phosphot-ylation, such as cyclin A (Krek 
et a/, 1995) . 
Our study has revealed tha t induction of keratinocyte growth 
arres t is associated with two signafu1g pathways: one mediating a 
decrease in E2F1 mRNA expression and another downregu lating 
E2F activity. Both of these pathways appear to be absent in 
carcinoma ce lls. An understanding of the regulation of these 
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pathways will lead to a better understanding of the events under-
lying neoplastic development. 
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